Panduta symptom is an Upadrava in Amlapitta Vyadhi
Not Applicable
- Conditions
- Health Condition 1: I95-I99- Other and unspecified disorders of the circulatory system
- Registration Number
- CTRI/2019/04/018652
- Lead Sponsor
- PDEAs Collage of Ayurved and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients must be suffering from Amlapitta Vyadhi more than 3Years
Exclusion Criteria
Amapitta having Upadrava other than Panduta
Known case of HIV,Auto immune Disorder,CKD
Haemoglobinopathies and Auto immune disorder of RBC;S
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Descriptive StudyTimepoint: Upadrava of Amlapitta Vyadhi will be assessed in Patients.
- Secondary Outcome Measures
Name Time Method Descriptive StudyTimepoint: Pitta prakopa lakshana will be assessed in Patients.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Panduta symptom manifestation in Amlapitta Vyadhi as observed in CTRI/2019/04/018652?
How does Ayurvedic Panduta symptom assessment compare to conventional diagnostic biomarkers for circulatory disorders?
Are there specific biomarkers associated with Amlapitta Vyadhi progression to I95-I99 circulatory system disorders?
What adverse events are commonly observed in Amlapitta Vyadhi patients with Panduta symptoms and how are they managed?
What combination therapies show promise for managing I95-I99 disorders in Ayurvedic and modern medical frameworks?